What is Sickle cell anemia ?( According to medical science and Allopathy )
Sickle-celldisease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and vaso-occlusion, is central to the pathophysiology of this disease, although the importance of chronic anaemia, haemolysis, and vasculopathy has been established. Clinical management is basic and few treatments have a robust evidence base. One of the main problems of sickle-celldisease in children is the development of cerebrovascular disease and cognitive impairment, and the role of blood transfusion and hydroxycarbamide for prevention of these complications is starting to be understood. Recurrent episodes of vaso-occlusion and inflammation result in progressive damage to most organs, including the brain, kidneys, lungs, bones, and cardiovascular system, which becomes apparent with increasing age. Most people with sickle-celldisease live in Africa,
where little is known about this disease.
LMNT opinion about this disease: We proved already that our therapy can cure sickle cell anemia whether in alopathy they doesn't know much about this this disease. Actually cell need good blood supply for it's own nourishment, blood transport oxygen and nutrition for nourishment but when cells get sicked then it's unable to absorbed it's own food and damaged completely.
 |
| LMNT treatment paper (miracle in 6days) |
Why LMNT is successful in this disease: Our method is based on Acid / Alkali concept, so in this case when our blood become acidic (bellow 7.44ph) so when acid is high in the blood cells become inflamed and cells receptors are collapsed and sicked. We are neutralizing acid and restore acid / alkali balance of the blood and just in few days patients get result.. See bellow the original blood report of patient, Before treatment and after treatment...
 |
| Report before treatment |
 |
| Report after treatment |
Fore more details please call 00919331935169
Sickle-celldisease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and vaso-occlusion, is central to the pathophysiology of this disease, although the importance of chronic anaemia, haemolysis, and vasculopathy has been established. Clinical management is basic and few treatments have a robust evidence base. One of the main problems of sickle-celldisease in children is the development of cerebrovascular disease and cognitive impairment, and the role of blood transfusion and hydroxycarbamide for prevention of these complications is starting to be understood. Recurrent episodes of vaso-occlusion and inflammation result in progressive damage to most organs, including the brain, kidneys, lungs, bones, and cardiovascular system, which becomes apparent with increasing age. Most people with sickle-celldisease live in Africa, where little is known about this disease.
No comments:
Post a Comment